(Q38778227)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27079211%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

title

Significance of survivin as a prognostic factor and a therapeutic target in endometrial cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27079211%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27079211%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Osamu Wada-Hiraike

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27079211%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

4

Yuji Ikeda

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27079211%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

17

Yutaka Osuga

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27079211%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

15

Kei Kawana

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27079211%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

2

Kenbun Sone

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27079211%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

13

Takahide Arimoto

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27079211%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

author name string

Agapiti Hipoliti Chuwa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27079211%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Tomohiko Fukuda

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27079211%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Kanako Inaba

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27079211%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Chinami Makii

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27079211%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Makoto Takeuchi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27079211%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Shinya Oki

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27079211%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Aki Miyasaka

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27079211%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Tomoko Kashiyama

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27079211%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Hiroyuki Kuramoto

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27079211%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Tetsu Yano

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27079211%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

Tomoyuki Fujii

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27079211%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

language of work or name

English

0 references

publication date

16 April 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27079211%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27079211%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

volume

141

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27079211%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27079211%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

page(s)

564-569

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27079211%20AND%20SRC:MED&resulttype=core&format=json

Cancer treatment and survivorship statistics, 2014

1 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.04.003

European Code against Cancer 4th Edition: Obesity, body fatness and cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.04.003

Prognostic value of survivin expression in breast cancer patients: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.04.003

Survivin: A molecular biomarker in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.04.003

Inhibitor of apoptosis proteins in hematological malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.04.003

Meta-analysis: prognostic value of survivin in patients with hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.04.003

Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.04.003

Survivin - biology and potential as a therapeutic target in oncology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.04.003

Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.04.003

Overexpression of BMI-1 correlates with drug resistance in B-cell lymphoma cells through the stabilization of survivin expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.04.003

Inhibitor of apoptosis protein (IAP) survivin is upregulated by oncogenic c-H-Ras

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.04.003

Survivin expression in endometrial carcinoma: a tissue microarray study with correlation with PTEN and STAT-3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.04.003

Putative tumor suppression function of SIRT6 in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.04.003

Interleukin enhancer-binding factor 3/NF110 is a target of YM155, a suppressant of survivin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.04.003

YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.04.003

A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.04.003

Phase II, multicenter, open-label, randomized study of YM155 plus docetaxel as first-line treatment in patients with HER2-negative metastatic breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.04.003

Multicenter phase II trial of YM155, a small-molecule suppressor of survivin, in patients with advanced, refractory, non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.04.003

Integrated genomic characterization of endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.04.003

RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.04.003

Successful immortalization of endometrial glandular cells with normal structural and functional characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.04.003

Establishment and characterization of human endometrial cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.04.003

PIK3CA cooperates with other phosphatidylinositol 3'-kinase pathway mutations to effect oncogenic transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.04.003

Genotype-dependent efficacy of a dual PI3K/mTOR inhibitor, NVP-BEZ235, and an mTOR inhibitor, RAD001, in endometrial carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.04.003

Anti-tumor activity of olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, in cultured endometrial carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.04.003

COX-2 and survivin are overexpressed and positively correlated in endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.04.003

Co-expression of survivin, c-erbB2, and cyclooxygenase-2 (COX-2): prognostic value and survival of endometrial cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.04.003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.04.003

Survivin, cancer networks and pathway-directed drug discovery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.04.003

Characterization of TP53 and PI3K signaling pathways as molecular targets in gynecologic malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.04.003

The "survivin suppressants" NSC 80467 and YM155 induce a DNA damage response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.04.003

YM155 potently kills acute lymphoblastic leukemia cells through activation of the DNA damage pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.04.003

YM155 induces apoptosis through downregulation of specificity protein 1 and myeloid cell leukemia-1 in human oral cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2016.04.003

10.1016/J.YGYNO.2016.04.003

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27079211%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

1 reference